Private equity firms Blackstone and TPG were reportedly in advanced negotiations to acquire Hologic, with a potential take-private deal valued at more than $17 billion, including debt. The discussed price was said to be above $75 per share.
Sources familiar with the matter indicated that the firms had agreed on the terms of the acquisition and had successfully lined up the necessary debt financing. This development suggests a high likelihood of a definitive agreement being reached soon.
The news of advanced talks and a substantial valuation signals a significant potential premium for Hologic shareholders. This follows earlier reports of renewed interest from the private equity firms after an initial offer was rejected.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.